2023 Q4 Form 10-Q Financial Statement

#000118518523001176 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $22.25M $17.48M
YoY Change 113.52% 64.45%
Cost Of Revenue $14.45M $10.80M
YoY Change 148.78% 152.96%
Gross Profit $7.795M $6.680M
YoY Change 69.09% 5.03%
Gross Profit Margin 35.04% 38.22%
Selling, General & Admin $8.650M $7.072M
YoY Change 16.58% 24.51%
% of Gross Profit 110.97% 105.87%
Research & Development $1.323M $1.315M
YoY Change 35.0% -8.81%
% of Gross Profit 16.97% 19.69%
Depreciation & Amortization $654.0K $37.50K
YoY Change -95.96% 6.49%
% of Gross Profit 8.39% 0.56%
Operating Expenses $10.63M $9.044M
YoY Change -56.5% -4.02%
Operating Profit -$2.832M -$2.364M
YoY Change -85.71% -22.82%
Interest Expense -$3.574M $4.200M
YoY Change -5.95% 363.08%
% of Operating Profit
Other Income/Expense, Net -$998.0K -$624.0K
YoY Change -337.62%
Pretax Income -$29.85M -$2.988M
YoY Change 28.62% -80.26%
Income Tax $151.0K $128.0K
% Of Pretax Income
Net Earnings -$30.00M -$3.116M
YoY Change 29.55% -79.46%
Net Earnings / Revenue -134.85% -17.83%
Basic Earnings Per Share -$0.60
Diluted Earnings Per Share -$5.43 -$0.60
COMMON SHARES
Basic Shares Outstanding 5.386M shares 52.38M shares
Diluted Shares Outstanding 5.232M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.18M $15.85M
YoY Change -13.0% 44.05%
Cash & Equivalents $12.18M $15.85M
Short-Term Investments
Other Short-Term Assets $12.83M $8.324M
YoY Change 72.8% 873.41%
Inventory
Prepaid Expenses
Receivables $859.0K $698.0K
Other Receivables $12.83M $8.324M
Total Short-Term Assets $89.87M $80.34M
YoY Change 51.76% 17.48%
LONG-TERM ASSETS
Property, Plant & Equipment $306.0K $1.660M
YoY Change -81.95% -2.48%
Goodwill $26.75M $26.75M
YoY Change 0.0% 0.48%
Intangibles $5.059M $5.678M
YoY Change -24.93% -74.65%
Long-Term Investments $227.0K
YoY Change -84.87%
Other Assets $2.403M $1.826M
YoY Change 1120.61% 881.52%
Total Long-Term Assets $38.80M $39.93M
YoY Change 0.93% -26.08%
TOTAL ASSETS
Total Short-Term Assets $89.87M $80.34M
Total Long-Term Assets $38.80M $39.93M
Total Assets $128.7M $120.3M
YoY Change 31.75% -1.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.819M $67.40M
YoY Change -94.04% 196.9%
Accrued Expenses $5.755M $580.0K
YoY Change 150.22% -3.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $15.00K
YoY Change 16.55%
Long-Term Debt Due $15.00K $15.00K
YoY Change 16.55%
Total Short-Term Liabilities $85.54M $73.17M
YoY Change 132.85% 168.3%
LONG-TERM LIABILITIES
Long-Term Debt $15.91M $61.55M
YoY Change -74.23% 9561.87%
Other Long-Term Liabilities $3.720M $3.567M
YoY Change 238.18% 224.27%
Total Long-Term Liabilities $15.91M $61.55M
YoY Change -74.23% 9561.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $85.54M $73.17M
Total Long-Term Liabilities $15.91M $61.55M
Total Liabilities $105.2M $138.3M
YoY Change 5.62% 57.69%
SHAREHOLDERS EQUITY
Retained Earnings -$152.6M -$122.6M
YoY Change 52.93% 90.77%
Common Stock $6.000K $5.000K
YoY Change -87.76% -89.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.49M -$24.69M
YoY Change
Total Liabilities & Shareholders Equity $128.7M $120.3M
YoY Change 31.75% -1.75%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$30.00M -$3.116M
YoY Change 29.55% -79.46%
Depreciation, Depletion And Amortization $654.0K $37.50K
YoY Change -95.96% 6.49%
Cash From Operating Activities $5.577M $4.454M
YoY Change 3618.0% -130.63%
INVESTING ACTIVITIES
Capital Expenditures $255.0K $58.00K
YoY Change 325.0% -138.67%
Acquisitions
YoY Change
Other Investing Activities $2.620M $0.00
YoY Change -458.9% -100.0%
Cash From Investing Activities $2.365M -$58.00K
YoY Change -399.37% -95.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.997M -1.000K
YoY Change 265.49%
NET CHANGE
Cash From Operating Activities 5.577M 4.454M
Cash From Investing Activities 2.365M -58.00K
Cash From Financing Activities -2.997M -1.000K
Net Change In Cash 4.945M 4.395M
YoY Change -438.7% -127.75%
FREE CASH FLOW
Cash From Operating Activities $5.577M $4.454M
Capital Expenditures $255.0K $58.00K
Free Cash Flow $5.322M $4.396M
YoY Change 5813.33% -130.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34294
dei Entity Registrant Name
EntityRegistrantName
RYVYL INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-3962936
dei Entity Address Address Line1
EntityAddressAddressLine1
3131 Camino Del Rio North, Suite 1400
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92108
dei City Area Code
CityAreaCode
619
dei Local Phone Number
LocalPhoneNumber
-631-8261
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
RVYL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5386141 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15845000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13961000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
52510000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
26873000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
111000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
82000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
698000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1156000 usd
CY2023Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2211000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3917000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
8324000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7427000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2959000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9798000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
80336000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
59215000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1660000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1696000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1826000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
197000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
26753000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
26753000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5678000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6739000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3784000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1533000 usd
CY2023Q3 us-gaap Investments
Investments
227000 usd
CY2022Q4 us-gaap Investments
Investments
1524000 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
39928000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
38442000 usd
CY2023Q3 us-gaap Assets
Assets
120264000 usd
CY2022Q4 us-gaap Assets
Assets
97657000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3592000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1630000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5133000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3662000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
8000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1728000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
63805000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
28912000 usd
CY2023Q3 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
15000 usd
CY2022Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
14000 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
45000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
255000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
572000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
534000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
73170000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36735000 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
61549000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
61735000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3567000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1109000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
138286000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
99579000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
6664000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
17500000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
17500000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5212586 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5212586 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4972736 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4972736 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q3 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
0 usd
CY2022Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
0 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96741000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96256000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
641000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
309000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2729000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
657000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2299000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1899000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4880000 usd
CY2023Q3 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
62000 usd
CY2022Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
0 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1208000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1596000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122578000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99772000 usd
CY2023Q3 rvyl Shares To Be Returned
SharesToBeReturned
0 usd
CY2022Q4 rvyl Shares To Be Returned
SharesToBeReturned
7000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-24686000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1922000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120264000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97657000 usd
CY2023Q3 us-gaap Revenues
Revenues
17480000 usd
CY2022Q3 us-gaap Revenues
Revenues
10630000 usd
us-gaap Revenues
Revenues
43620000 usd
us-gaap Revenues
Revenues
21806000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
10800000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
4333000 usd
us-gaap Cost Of Revenue
CostOfRevenue
25703000 usd
us-gaap Cost Of Revenue
CostOfRevenue
11343000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
6680000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
6297000 usd
us-gaap Gross Profit
GrossProfit
17917000 usd
us-gaap Gross Profit
GrossProfit
10463000 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
45000 usd
CY2022Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
438000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
153000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1106000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1315000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1442000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4434000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5300000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3041000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1186000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6709000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4332000 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2605000 usd
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2385000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
8232000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
7481000 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
1234000 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
1032000 usd
us-gaap Professional Fees
ProfessionalFees
5651000 usd
us-gaap Professional Fees
ProfessionalFees
3704000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
147000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
9044000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
9423000 usd
us-gaap Operating Expenses
OperatingExpenses
27387000 usd
us-gaap Operating Expenses
OperatingExpenses
29532000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2364000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3126000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9470000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-19069000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-65000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1802000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3310000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7415000 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4183000 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-1632000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
9626000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
11540000 usd
CY2023Q3 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
-1331000 usd
CY2022Q3 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
-8105000 usd
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
-1518000 usd
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
-9762000 usd
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
6909000 usd
CY2022Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-4143000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
6580000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
14592000 usd
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1929000 usd
CY2022Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
4142000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 usd
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-368000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-286000 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-25000 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
63000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1474000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
298000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-624000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12723000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13490000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14113000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2988000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15849000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22960000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33182000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
128000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
138000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3116000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-15884000 usd
us-gaap Net Income Loss
NetIncomeLoss
-23098000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33219000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3116000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-15884000 usd
us-gaap Net Income Loss
NetIncomeLoss
-23098000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33219000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-317000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-311000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-389000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-708000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3433000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16195000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23487000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33927000 usd
CY2023Q3 rvyl Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.6
CY2022Q3 rvyl Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-3.37
rvyl Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-4.48
rvyl Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-7.54
CY2023Q3 rvyl Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
5231588 shares
CY2022Q3 rvyl Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
4710495 shares
rvyl Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
5160499 shares
rvyl Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
4407280 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1922000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
31000 usd
CY2023Q1 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
294000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8037000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-9634000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
130000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
416000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
315000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12018000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-21383000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
20000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3433000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-24686000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29468000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
126000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000 usd
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3237000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2110000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
167000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-29427000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-786000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
79000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1496000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
9826000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
12091000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
22308000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
133000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
459000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
7088000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
1709000 usd
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
820000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-15884000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
14792000 usd
us-gaap Net Income Loss
NetIncomeLoss
-23098000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33219000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1899000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4880000 usd
us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
246000 usd
us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
54000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
309000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2729000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
9626000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
11540000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
6580000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
14592000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1518000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9762000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-457000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
308000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6841000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1227000 usd
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
896000 usd
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
20000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1480000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-48000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1962000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-442000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1333000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
348000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
554000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
534000 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
34893000 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
7566000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27584000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12347000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
78000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
102000 usd
us-gaap Payments For Deposits
PaymentsForDeposits
0 usd
us-gaap Payments For Deposits
PaymentsForDeposits
1451000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
500000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
28811000 usd
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0 usd
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
16000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-78000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46864000 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
4057000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
0 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-6000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
11000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10052000 usd
us-gaap Cash Acquired In Excess Of Payments To Acquire Business
CashAcquiredInExcessOfPaymentsToAcquireBusiness
0 usd
us-gaap Cash Acquired In Excess Of Payments To Acquire Business
CashAcquiredInExcessOfPaymentsToAcquireBusiness
18677000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
27495000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-50586000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1410000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40834000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89559000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68355000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37563000 usd
us-gaap Interest Paid
InterestPaid
2709000 usd
us-gaap Interest Paid
InterestPaid
4907000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
rvyl Interest Accrual From Convertible Debt Converted To Preferred Stock
InterestAccrualFromConvertibleDebtConvertedToPreferredStock
2271000 usd
rvyl Interest Accrual From Convertible Debt Converted To Preferred Stock
InterestAccrualFromConvertibleDebtConvertedToPreferredStock
0 usd
us-gaap Stock Issued1
StockIssued1
3000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
CY2023Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10 reverse stock split
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Use of Estimates</b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Reclassifications</b></p><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations or cash flows.</p>
CY2023Q2 rvyl Offering Value
OfferingValue
40000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
200000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1998000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1920000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
338000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
224000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1660000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1696000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
37503 usd
CY2022Q3 us-gaap Depreciation
Depreciation
35217 usd
us-gaap Depreciation
Depreciation
113568 usd
us-gaap Depreciation
Depreciation
102334 usd
CY2023Q3 us-gaap Goodwill
Goodwill
26753000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
26753000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10487000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-4809000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5678000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9762000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-3023000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6739000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
619000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2002000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1844000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
992000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
148000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
73000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5678000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
61564000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
61749000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
15000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
14000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
61549000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
61735000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
4200000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
3400000 usd
us-gaap Interest Expense
InterestExpense
9600000 usd
us-gaap Interest Expense
InterestExpense
11500000 usd
CY2023Q3 us-gaap Interest Expense Other
InterestExpenseOther
40000.00 usd
CY2022Q3 us-gaap Interest Expense Other
InterestExpenseOther
1800000 usd
us-gaap Interest Expense Other
InterestExpenseOther
3500000 usd
us-gaap Interest Expense Other
InterestExpenseOther
5600000 usd
CY2021Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
18735000 usd
CY2022 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-18480000 usd
CY2022Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
255000 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
6370000 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-6580000 usd
CY2023Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
45000 usd
CY2021Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-11-05
CY2023Q3 us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
As part of the Exchange Agreement, the Company also agreed to allow for the conversion of up to an additional $9.0 million of principal (together with any accrued and unpaid interest thereon) of the Note at a conversion price equal to 97.5% of the lower of (x) the then in effect conversion price and (y) the lowest volume weighted average price of the Company’s common stock during the five trading days immediately prior to such conversion; and the Investor agreed to waive any interest that would otherwise accrue on the Note during the period commencing on April 1, 2023 through, and including, December 31, 2023.
CY2023Q3 us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
Subject to the satisfaction of certain equity conditions, the terms of the Restructuring Agreement require the holder to voluntarily convert certain interest payments when due under the Note at 95% of the lower of (i) the then in effect conversion price and (ii) the lowest volume weighted average price of our common stock during the five trading days immediately prior to such conversion.
CY2023Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
4297000 usd
CY2023Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000 shares
CY2023Q3 rvyl Preferred Shares Issued And Outstanding
PreferredSharesIssuedAndOutstanding
6000 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
6664000 usd
CY2023Q3 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
6900000 usd
CY2023Q3 rvyl Common Stock Issuable Upon Conversion
CommonStockIssuableUponConversion
3000000 shares
us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
Each share of Series A Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into shares of common stock either (i) at the fixed conversion price then in effect, which initially is $2.00 (subject to standard antidilution adjustments and adjustments as a result of subsequent issuances of securities where the effective price of the common stock is less than the then current fixed conversion price) or (ii) at the Alternate Conversion Price, as defined below. The Certificate of Designations also provides that in the event of certain “Triggering Events,” any holder may, at any time, convert any or all of such holder’s Series A Preferred Stock at a conversion rate equal to the product of (i) the Alternate Conversion Price and (ii) 115% of the value of the Preferred Stock subject to such conversion. “Triggering Events” include, among others, (i) a failure to timely deliver shares of common stock, upon a conversion, (ii) a suspension of trading on the principal trading market or the failure to be traded or listed on the principal market for five days or more, (iii) the failure to pay any dividend to the holders of Series A Preferred Stock when required, (iv) the failure to remove restrictive legends when required, (v) the Company’s default in payment of indebtedness in an aggregate amount of $2 million or more, (vi) proceedings for a bankruptcy, insolvency, reorganization or liquidation, which are not dismissed with 30 days, (vii) commencement of a voluntary bankruptcy proceeding, and (viii) final judgments against the Company for the payment of money in excess of $2 million. “Alternate Conversion Price” means the lower of (i) the applicable conversion price then in effect and (ii) the greater of (x) $0.24 and (y) 97.5% of the lowest volume weighted average price of the common stock during the five consecutive trading day period ending and including the trading day immediately preceding the delivery of the applicable conversion notice.
CY2023Q3 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
2
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
39157 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
50.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3682 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
36.6
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1242 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
9634 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
65.6
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
31963 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.51
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
49248 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
31963 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
46.51
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
49248 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
31963 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
40.29
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1820 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
50.38
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
30143 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.27
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
30143 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
46.27
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
102400 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
19.4
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
57966 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
21.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
44434 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16.52
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
66728 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
44027 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
62672 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
12.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
16617 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
10.23
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
31466 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
7.88
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
70084 shares
CY2023Q3 us-gaap Property Subject To Or Available For Operating Lease Number Of Units
PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits
3 pure
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
45593 usd
CY2023Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
100000 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
800000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
600000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.122 pure
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
192000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1102000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1161000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1165000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
883000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
878000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5381000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1242000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4139000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
572000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3567000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2023Q3 us-gaap Revenues
Revenues
17480000 usd
CY2022Q3 us-gaap Revenues
Revenues
10630000 usd
us-gaap Revenues
Revenues
43620000 usd
us-gaap Revenues
Revenues
21806000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2364000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3126000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9470000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-19069000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3116000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-15884000 usd
us-gaap Net Income Loss
NetIncomeLoss
-23098000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33219000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
657000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2299000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1899000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4880000 usd
CY2023Q3 us-gaap Noncurrent Assets
NoncurrentAssets
34090000 usd
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
35187000 usd
CY2023Q3 us-gaap Assets
Assets
120264000 usd
CY2022Q4 us-gaap Assets
Assets
97657000 usd
CY2022Q3 us-gaap Payments For Deposits
PaymentsForDeposits
685000 eur
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001419275

Files In Submission

Name View Source Status
rvyl-20230930_cal.xml Edgar Link unprocessable
rvyl-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001185185-23-001176-index-headers.html Edgar Link pending
0001185185-23-001176-index.html Edgar Link pending
0001185185-23-001176.txt Edgar Link pending
0001185185-23-001176-xbrl.zip Edgar Link pending
ex_591319.htm Edgar Link pending
ex_591320.htm Edgar Link pending
ex_591321.htm Edgar Link pending
ex_591322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rvyl-20230930.xsd Edgar Link pending
ryvyl20230930_10q.htm Edgar Link pending
Show.js Edgar Link pending
rvyl-20230930_def.xml Edgar Link unprocessable
rvyl-20230930_pre.xml Edgar Link unprocessable
ryvyl20230930_10q_htm.xml Edgar Link completed